Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid and manufacture of a batch for preclinical studies.
This development required hydration and homogenization at high temperature and syringe filling at controlled temperature.
Our team is drawing on its many years of experience and past success to take the necessary steps to produce this product in clinical pre-series.
No company is more future-oriented at the moment than SyrhaTech: a Biotech medical device company…
For the past four months, SyrhaTech has been in partnership with the learned society ISHAS…
The SyrhaTech team is made up of people from Europe’s four corners. Everyone is very…
SyrhaTech is proud to announce that we have joined the “CDMO France” association. CDMO France…
At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…
We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…
Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…
We’re delighted to announce that our team will be taking part in the IMCAS 2024…
In the field of sterile medical device manufacturing, the terminal sterilization of your products is…
The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…
